Deferred Tax Assets, Valuation Allowance of BIO-TECHNE Corp from 30 Jun 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIO-TECHNE Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2010 to 30 Jun 2025.
  • BIO-TECHNE Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $33,769,000, a 75% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $33,769,000 +$14,504,000 +75% 30 Jun 2025 10-K 22 Aug 2025 2025 FY
Q2 2024 $19,265,000 +$9,921,000 +106% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q2 2023 $9,344,000 -$122,000 -1.3% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q2 2022 $9,466,000 +$2,801,000 +42% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q2 2021 $6,665,000 -$35,000 -0.52% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q2 2020 $6,700,000 -$274,000 -3.9% 30 Jun 2020 10-K 24 Aug 2022 2022 FY
Q2 2019 $6,974,000 +$3,996,000 +134% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q2 2018 $2,978,000 -$363,000 -11% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q2 2017 $3,341,000 -$3,860,000 -54% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q2 2016 $7,201,000 +$4,643,000 +182% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q2 2015 $2,558,000 +$752,000 +42% 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q2 2014 $1,806,000 +$1,806,000 30 Jun 2014 10-K 31 Aug 2015 2015 FY
Q2 2013 $0 $0 30 Jun 2013 10-K 29 Aug 2014 2014 FY
Q2 2012 $0 -$3,016,000 -100% 30 Jun 2012 10-K 29 Aug 2012 2012 FY
Q2 2011 $3,016,000 +$60,000 +2% 30 Jun 2011 10-K 29 Aug 2012 2012 FY
Q2 2010 $2,956,000 30 Jun 2010 10-K 29 Aug 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.